Advanced Search
He Song, . Clinicopathologic, Mucin Histochemical and CEA Immunohistochemical Study in Adenocarcinoma of the Bladder[J]. Cancer Research on Prevention and Treatment, 1996, 23(5): 286-288.
Citation: He Song, . Clinicopathologic, Mucin Histochemical and CEA Immunohistochemical Study in Adenocarcinoma of the Bladder[J]. Cancer Research on Prevention and Treatment, 1996, 23(5): 286-288.

Clinicopathologic, Mucin Histochemical and CEA Immunohistochemical Study in Adenocarcinoma of the Bladder

More Information
  • Clinical and pathologic feature in 18 adenocarcinomas of the bladder were discussed. Sixteen cases wer.primary adenocarcinoma and the other 2 that of the metastasis. There were 14 males and 4 females. Their age ranged from 4o to 71with an average of 54 years. The clinical symptoms were non-particularity, except of discharge mucin urine to suggested mucinous carcinoma. Noeplasm alone resection was carried out for 6 of 16 primary adenocarcinomas, and partial cystectomy was carried out for the other 10.Total of 5-year survial rate of adenocarcinoma of the bladder was 33%.Histomorphology of adenocarcinoma of the bladder could be classified into two types:1.pure type,14 cases (tubular adenocarcinoma,8 cases;papillary adenocarcinoma, 4 cases;and mucinouscarcinoma,2 cases);2.Mixed type,4 cases (adenocarcinoma mixed with transitional cell carcinoma).Follow-up data showed that the patients prognosis of mixed type tumor were better than the pure type. Mucin histochemical staining confirmed that sialomucins predominatde over neutral mucins for adenocarcinoma of the bladder. Our study suggested also that CEA immunohistochemical staining was significant to estimate prognosis for adenocarcinoma of the bladder.
  • 1 Thomas DG, Ward Am, Williams JL. A study of 52 cases of adenocarcinoma of the bladder. Br J Urol,1971,43:4.
    2 Anderstrom C, Johansson SL, Schultz LN. Primary adenocarcinoma of the urinary bladder: a clinicopathologic and prognostic study. Cancer, 1983, 52:1273.
    3 Bennett JK, Wheatley JK, Walton KN, Ten year expe-rience with adenocarcinoma of the bladder. J Urol,1984, 131:262.
    4 鲁学军,杨伟力,张志宏,等.膀胧膝痛(附31例报告).中华泌尿外科杂志,1994, 15:44.
    5 Kamat MR, Kulkarni JN, Tongaonkar HB. Adenocarcinoma of the bladder: study of 14 cases and review of the literature. Br J Urol, 1991,68:254.
    6 Smith JA, Herr HW, Middleton RG. Bladder carcinosarcoma, histologic varition in metastatic lesions, Jurol, 1983, 129:829.
    7 Schobory T W, Saffos RO, Rodrigues AP et al. Carcinosarcoma of the bladder. J Urol, 1980, 124:724.
    8 Gill HS, Dhillon HK, Woodhouse CRJ. Adenocarcinoma of the urimary bladder. Br J Urol,1989, 64:138.
    9 Wells M, Anderson K, Mucin histochemistry of cystitis glandularis and primary adenocarcinoma of the uri- nary bladder. Arch Pathol Lab Med, 1985, 109:59.
    10 张思孝,邓显昭,饶文裕,等.脐尿管腺癌及原发性膀脱腺癌.中华泌尿外科杂志,1986, 7:223.
    11 董惠群.膀胧腺痛(附20例报告).中华泌尿外科杂志,1983, 4:154.
    12 林栋,吴克让.膀耽腺癌18例分析.中华肿瘤杂志,1984, 6:220.
    13 Abenoza P, Manivel C, Fraley EE. Primary adenocarcinoma of urinary bladder: clinicopathologic study of 16 cases. Urology, 1987, 29:9.
  • Related Articles

    [1]Wu Shisheng, Shao Lihua, LI Shangr, Zhang Fei, Xie Hong, Zhang Chunxiu, Liu Guiping. Correlation of MMP-9 and MMP-2 Gene SNPs with Hepatocellular Carcinoma Invasion and Metastasis[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 683-686. DOI: 10.3971/j.issn.1000-8578.2012.06.017
    [2]Chen Shouren, Wang Zhanxiang, Shen Shanghang, Tan Guowei, Liu Xiyao, Zhu Hongwei. miR-126 Inhibits Invasion of Human Brain Glioma Cells by Decreasing MMP-2[J]. Cancer Research on Prevention and Treatment, 2012, 39(03): 264-266. DOI: 10.3971/j.issn.1000-8578.2012.03.005
    [3]ZHANG Jun-xiang, LIU Zhang-suo, WANG Jian-jun. Expression and Significance of ANGPTL3,MMP-2 and MMP-9 in Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(09): 1028-1030. DOI: 10.3971/j.issn.1000-8578.2011.09.013
    [4]XUAN Xiao-yan, LI Shan-shan, ZHENG Xian-zhao, LI Na, WANG Feng. Effect of Silencing STAT3 by siRNA on Expression of MMP-2 in Esophageal Carcinoma Cell Line EC-1[J]. Cancer Research on Prevention and Treatment, 2010, 37(04): 395-397. DOI: 10.3971/j.issn.1000-8578.2010.04.007
    [5]ZHAO Bin-bin, ZHU Yun-kui, LI Ji-dong, WANG Shu, LIU Wei. Influence of Tumor-host Cooperation in Regulating MMP-2 and MMP-9 Expression in Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2009, 36(09): 737-740. DOI: 10.3971/j.issn.1000-8578.2009.09.005
    [6]WAN Zhen-ling, HU Zhong-liang, LIU Bao-an. TGFβ1 Upregulates Expression of MMP-2 and MMP-9 through ERK Signaling Pathway in Gastric Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2009, 36(02): 91-94. DOI: 10.3971/j.issn.1000-8578.2009.02.003
    [7]LUO Hong-bo, LIU Xiu-heng, CHEN Zhimin, ZHANG De-Ling. Immunohistochemical Study of COX-2 and MMP-2 in Human Renal Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2005, 32(06): 354-346. DOI: 10.3971/j.issn.1000-8578.2783
    [8]ZHOU Hong-yan, DIAO Lu-ming, CHEN Ying, DENG Hao, LIU Li-jiang. Relationship of the Expression of MMP-2 、MMP-9 、TIMP-1 with Lymph Node Metastasis and Survival Time in Gastric Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2005, 32(05): 274-275. DOI: 10.3971/j.issn.1000-8578.1272
    [9]CAO Ge, SHEN Zhi-xiang, HUANG Jie-an, et al. Correlation between expression of CD44v6, MMP-2 and nm23-H1 in colorectal carcinoma and its clinicalopathological characters[J]. Cancer Research on Prevention and Treatment, 2002, 29(01): 53-56. DOI: 10.3971/j.issn.1000-8578.126
    [10]ZHAO Yue-wu, KONG Ling-fei, TANG Hua, et al. Study on Relationship between Activity of MMP-2(72KD),MMP-9(92KD) and Invasion Metastasis of Human Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2000, 27(05): 370-372. DOI: 10.3971/j.issn.1000-8578.3400

Catalog

    He Song

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (1776) PDF downloads (395) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return